Memo Therapeutics
Series AMemo Therapeutics raised €14M in a Series A round in Nov 2020. The company is based in Zurich, Switzerland. Investors in the round: Redalpine. Data as of 4 Nov 2026.
Amount raised
€14M
€13,900,000
Native amount
13,900,000 EUR
Stage
Series A
series a
Investors
1
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €14M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.